Medicare Alzheimer's Drug Study Criteria Would Be Out Of Reach In Many States – Analysis

Alzheimer's patient groups continue to argue against the CMS draft national coverage determination on Aduhelm, but effort to meet with HHS Secretary Xavier Becerra is thwarted.